ACTIVE

MEDISCH KABINET DOKTER BRUNO SEYNHAVE

Financial year 2025 · Closed on 30/06/2025

Net result254 k €-6,1 %over 1 year
Gross margin400 k €-3,5 %over 1 year
Equity1 M €+13,9 %over 1 year

Identity

Source · BCE/KBO

MEDISCH KABINET DOKTER BRUNO SEYNHAVE is a Private limited company incorporated in 2004. Its registered office is in Haaltert.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0866.478.630
Incorporation
22/07/2004
Legal form
Private limited company
Registered office
Vondelen(DE) 6
9450 Haaltert · FlandreSee on map
Contributed capital
20 000,00 €
Latest accounts
30/06/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 19 filings

Trend over 19 financial years

20252024202320222021
Income statement
Gross margin400 k €414,5 k €163,5 k €186,9 k €273,7 k €
EBITDA397,8 k €412,6 k €161,5 k €183,2 k €271 k €
Operating result376,7 k €399,7 k €144 k €166,1 k €253,7 k €
Net result254 k €270,4 k €92,8 k €114 k €175,7 k €
Balance sheet
Equity1 M €893,5 k €723,1 k €1,1 M €984,9 k €
Total assets1,2 M €1,1 M €954,4 k €1,1 M €1 M €
Cash147,8 k €162,6 k €66,4 k €126,2 k €75,3 k €
Debts167,2 k €199,2 k €231,3 k €51 k €35,3 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 3 ended

Active mandates

Bruno SEYNHAVE

Director · since 22 juillet 2004

Active

Ended mandates

BRUNO SEYNHAVE

Manager · since 15 juillet 2004

Ended
Bruno Seynhave

Director

Ended
BRUNO SEYNHAVE

Manager

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date17/12/202520/12/202430/01/202431/01/202330/12/202115/09/2020
General meeting02/12/202502/12/202422/12/202331/12/202206/09/202107/09/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/06/202502/12/202517/12/2025DutchPDF
Micro model30/06/202402/12/202420/12/2024DutchPDF
Micro model30/06/202322/12/202330/01/2024DutchPDF
Micro model30/06/202231/12/202231/01/2023DutchPDF
Micro model30/06/202106/09/202130/12/2021DutchPDF
Micro model30/06/202007/09/202015/09/2020DutchPDF
Micro model30/06/201902/09/201909/09/2019DutchPDF
Micro model30/06/201803/09/201821/09/2018DutchPDF
Micro model30/06/201704/09/201719/10/2017DutchPDF
Abridged model30/06/201605/09/201612/09/2016DutchPDF
Abridged model30/06/201507/09/201518/09/2015DutchPDF
Abridged model30/06/201401/09/201422/09/2014DutchPDF
Abridged model30/06/201302/09/201320/09/2013DutchPDF
Abridged model30/06/201203/09/201226/09/2012DutchPDF
Abridged model30/06/201105/09/201130/09/2011DutchPDF
Abridged model30/06/201006/09/201004/10/2010DutchPDF
Abridged model30/06/200907/09/200920/09/2009DutchPDF
Abridged model30/06/200802/09/200802/09/2008DutchPDF
Abridged model30/06/200703/09/200718/09/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 3 ended

Active mandates

Bruno SEYNHAVE

Director · since 22 juillet 2004

Active

Ended mandates

BRUNO SEYNHAVE

Manager · since 15 juillet 2004

Ended
Bruno Seynhave

Director

Ended
BRUNO SEYNHAVE

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates20/07/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares05/03/2018
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares07/01/2014
    KAPITAAL - AANDELEN
    PDF
  • Other02/03/2009
    DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Registered office13/12/2004
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other30/07/2004
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025254 k €↓
  2. 2024
    Annual accounts 2024270,4 k €↑
  3. 2023
    Annual accounts 202392,8 k €↓
  4. 2023
    Name changeMEDISCH KABINET DOKTER BRUNO SEYNHAVE
  5. 2022
    Annual accounts 2022114 k €↓
  6. 2022
    Name changeMed.kab.DR.Seynhave Bruno
  7. 2021
    Annual accounts 2021175,7 k €↑
  8. 2020
    Annual accounts 2020135,9 k €↑
  9. 2019
    Annual accounts 2019110,7 k €↓
  10. 2018
    Annual accounts 2018113,3 k €↑
  11. 2017
    Annual accounts 2017108,5 k €↓
  12. 2016
    Annual accounts 2016110 k €↓
  13. 2015
    Annual accounts 2015125,5 k €↓
  14. 2014
    Annual accounts 2014150,3 k €↑
  15. 2013
    Annual accounts 2013136 k €↑
  16. 2012
    Annual accounts 2012124,5 k €↓
  17. 2011
    Annual accounts 2011134,4 k €↓
  18. 2010
    Annual accounts 2010170 k €↓
  19. 2009
    Annual accounts 2009208,4 k €↑
  20. 2008
    Annual accounts 2008196,1 k €↑
  21. 2007
    Annual accounts 2007152 k €
  22. 22/07/2004
    IncorporationPrivate limited company